Amphastar Pharmaceuticals Total Liabilities and Share Holders Equity 2012-2024 | AMPH
Amphastar Pharmaceuticals total liabilities and share holders equity from 2012 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
Amphastar Pharmaceuticals Annual Total Liabilities and Share Holders Equity
(Millions of US $) |
| 2023 |
$1,513 |
| 2022 |
$742 |
| 2021 |
$672 |
| 2020 |
$631 |
| 2019 |
$587 |
| 2018 |
$514 |
| 2017 |
$451 |
| 2016 |
$428 |
| 2015 |
$390 |
| 2014 |
$389 |
| 2013 |
$339 |
| 2012 |
$317 |
| 2011 |
$0 |
| 2009 |
$300 |
Amphastar Pharmaceuticals Quarterly Total Liabilities and Share Holders Equity
(Millions of US $) |
| 2024-09-30 |
$1,545 |
| 2024-06-30 |
$1,492 |
| 2024-03-31 |
$1,574 |
| 2023-12-31 |
$1,513 |
| 2023-09-30 |
$1,545 |
| 2023-06-30 |
$1,378 |
| 2023-03-31 |
$774 |
| 2022-12-31 |
$742 |
| 2022-09-30 |
$727 |
| 2022-06-30 |
$724 |
| 2022-03-31 |
$716 |
| 2021-12-31 |
$672 |
| 2021-09-30 |
$652 |
| 2021-06-30 |
$666 |
| 2021-03-31 |
$646 |
| 2020-12-31 |
$631 |
| 2020-09-30 |
$614 |
| 2020-06-30 |
$600 |
| 2020-03-31 |
$573 |
| 2019-12-31 |
$587 |
| 2019-09-30 |
$586 |
| 2019-06-30 |
$601 |
| 2019-03-31 |
$545 |
| 2018-12-31 |
$514 |
| 2018-09-30 |
$481 |
| 2018-06-30 |
$452 |
| 2018-03-31 |
$450 |
| 2017-12-31 |
$451 |
| 2017-09-30 |
$438 |
| 2017-06-30 |
$444 |
| 2017-03-31 |
$436 |
| 2016-12-31 |
$428 |
| 2016-09-30 |
$429 |
| 2016-06-30 |
$409 |
| 2016-03-31 |
$395 |
| 2015-12-31 |
$390 |
| 2015-09-30 |
$395 |
| 2015-06-30 |
$399 |
| 2015-03-31 |
$397 |
| 2014-12-31 |
$389 |
| 2014-09-30 |
$401 |
| 2014-06-30 |
$397 |
| 2014-03-31 |
$345 |
| 2013-12-31 |
$339 |
| 2013-09-30 |
$0 |
| 2013-06-30 |
$0 |
| 2013-03-31 |
$0 |
| 2012-12-31 |
$317 |
| 2012-09-30 |
|
| 2012-06-30 |
|
| 2012-03-31 |
|
| 2011-12-31 |
$0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$2.142B |
$0.644B |
|
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
|
